Literature DB >> 25210561

Benign phyllodes tumour of the prostate: An extremely rare entity.

Ozgu Aydogdu1, Yusuf Ziya Atesci1, Ayhan Karakose1, Eren Demirtas2.   

Abstract

Benign phyllodes tumour (BPT) of the prostate is a very rare neoplasm. It is composed of hyperplastic and neoplastic glandular stromal proliferation. Patients with BPT of the prostate generally present with lower urinary tract symptoms and hematuria. BPT of the prostate can potentially cause recurrent obstructive symptoms. Complete transurethral resection (TUR) and close postoperative follow-up is recommended. A 59-year-old man presented with dysuria and obstructive urinary symptoms. Flexible cystoscopy revealed prostatic hyperplasia and a polypoidal lesion originating from the right lateral lobe of the prostate. Magnetic resonance imaging revealed a 3 × 2.5-cm mass lesion in the right lateral lobe of the prostate. TUR of the prostate was performed and the pathological examination revealed benign prostatic hyperplasia and benign phyllodes tumour of the prostate.

Entities:  

Year:  2014        PMID: 25210561      PMCID: PMC4137023          DOI: 10.5489/cuaj.2030

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  9 in total

1.  Phyllodes tumor of the prostate: recurrent obstructive symptom and stromal proliferative activity.

Authors:  Koji Shiraishi; Jun Mohri; Satoshi Eguchi; Yoriaki Kamiryo; Hayato Sanefuji
Journal:  Int J Urol       Date:  2004-09       Impact factor: 3.369

2.  Phyllodes tumor of the prostate.

Authors:  Tomomi Fujii; Keiji Shimada; Nobumichi Tanaka; Kiyohide Fujimoto; Noboru Konishi
Journal:  Pathol Int       Date:  2012-03       Impact factor: 2.534

3.  Primary breast sarcoma: a review of 33 cases with immunohistochemistry and prognostic factors.

Authors:  P Terrier; M J Terrier-Lacombe; H Mouriesse; S Friedman; M Spielmann; G Contesso
Journal:  Breast Cancer Res Treat       Date:  1989-01       Impact factor: 4.872

4.  Amplifications of EGFR gene and protein expression of EGFR, Her-2/neu, c-kit, and androgen receptor in phyllodes tumor of the prostate.

Authors:  Xiaoyan Wang; Timothy D Jones; Shaobo Zhang; John N Eble; David G Bostwick; Junqi Qian; Antonio Lopez-Beltran; Rodolfo Montironi; John J Harris; Liang Cheng
Journal:  Mod Pathol       Date:  2006-12-22       Impact factor: 7.842

Review 5.  Sarcomas and related proliferative lesions of specialized prostatic stroma: a clinicopathologic study of 22 cases.

Authors:  P B Gaudin; J Rosai; J I Epstein
Journal:  Am J Surg Pathol       Date:  1998-02       Impact factor: 6.394

6.  Phyllodes tumor of the prostate: long-term followup study of 23 cases.

Authors:  David G Bostwick; Deloar Hossain; Junqi Qian; Roxann M Neumann; Ping Yang; Robert H Young; P Anthony di Sant'agnese; Edward C Jones
Journal:  J Urol       Date:  2004-09       Impact factor: 7.450

7.  Phyllodes type of atypical prostatic hyperplasia.

Authors:  K Fujita; H Matsushima; A Munakata
Journal:  Int J Urol       Date:  1996-03       Impact factor: 3.369

8.  Phyllodes tumor of the prostate.

Authors:  B Aguilar; M Villalobos; M Sotomayor
Journal:  Urology       Date:  2008-10-18       Impact factor: 2.649

9.  Rare and challenging tumor entity: phyllodes tumor of the prostate.

Authors:  Andreas Bannowsky; Andreas Probst; Helmut Dunker; Tillmann Loch
Journal:  J Oncol       Date:  2009-12-22       Impact factor: 4.375

  9 in total
  2 in total

1.  Phyllodes tumor of the verumontanum: a case report.

Authors:  Jin Tang; Leye He; Zhi Long; Jingchao Wei
Journal:  Diagn Pathol       Date:  2015-06-16       Impact factor: 2.644

2.  Phyllodes tumor of the prostate: Long-term follow up of a rare condition.

Authors:  Ali Razi; Seyed Reza Yahyazadeh; Hiva Saffar
Journal:  Urol Case Rep       Date:  2019-09-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.